153 related articles for article (PubMed ID: 35153798)
21. Synthesis of Thymoquinone-Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial Agents.
Fröhlich T; Reiter C; Saeed MEM; Hutterer C; Hahn F; Leidenberger M; Friedrich O; Kappes B; Marschall M; Efferth T; Tsogoeva SB
ACS Med Chem Lett; 2018 Jun; 9(6):534-539. PubMed ID: 29937978
[TBL] [Abstract][Full Text] [Related]
22. Development and evaluation of novel artemisinin-isatin hybrids with potential anti-leukemic cytotoxicity.
Wang P; Zhang Z; Cao W; Zhang X
Front Oncol; 2023; 13():1112369. PubMed ID: 37124527
[TBL] [Abstract][Full Text] [Related]
23. Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling.
Abdel-Aziz HA; Eldehna WM; Keeton AB; Piazza GA; Kadi AA; Attwa MW; Abdelhameed AS; Attia MI
Drug Des Devel Ther; 2017; 11():2333-2346. PubMed ID: 28848327
[TBL] [Abstract][Full Text] [Related]
24. Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities.
Reiter C; Fröhlich T; Gruber L; Hutterer C; Marschall M; Voigtländer C; Friedrich O; Kappes B; Efferth T; Tsogoeva SB
Bioorg Med Chem; 2015 Sep; 23(17):5452-8. PubMed ID: 26260339
[TBL] [Abstract][Full Text] [Related]
25. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
[TBL] [Abstract][Full Text] [Related]
26. A milbemycin compound isolated from Streptomyces Sp. FJS31-2 with cytotoxicity and reversal of cisplatin resistance activity in A549/DDP cells.
Li XQ; Yue CW; Xu WH; Lü YH; Huang YJ; Tian P; Liu T
Biomed Pharmacother; 2020 Aug; 128():110322. PubMed ID: 32505822
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs.
Gagic Z; Ivkovic B; Srdic-Rajic T; Vucicevic J; Nikolic K; Agbaba D
Eur J Pharm Sci; 2016 Jun; 88():59-69. PubMed ID: 27063330
[TBL] [Abstract][Full Text] [Related]
28. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
29. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents.
Al-Blewi FF; Almehmadi MA; Aouad MR; Bardaweel SK; Sahu PK; Messali M; Rezki N; El Ashry ESH
Chem Cent J; 2018 Nov; 12(1):110. PubMed ID: 30387018
[TBL] [Abstract][Full Text] [Related]
31. Triazole linked mono carbonyl curcumin-isatin bifunctional hybrids as novel anti tubulin agents: Design, synthesis, biological evaluation and molecular modeling studies.
Sharma S; Gupta MK; Saxena AK; Bedi PM
Bioorg Med Chem; 2015 Nov; 23(22):7165-80. PubMed ID: 26515041
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole-Indole Hybrids.
Hassan AS; Moustafa GO; Awad HM; Nossier ES; Mady MF
ACS Omega; 2021 May; 6(18):12361-12374. PubMed ID: 34056388
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs.
von Bredow L; Schäfer TM; Hogenkamp J; Tretbar M; Stopper D; Kraft FB; Schliehe-Diecks J; Schöler A; Borkhardt A; Bhatia S; Held J; Hansen FK
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337131
[TBL] [Abstract][Full Text] [Related]
34. Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids.
Meleddu R; Petrikaite V; Distinto S; Arridu A; Angius R; Serusi L; Škarnulytė L; Endriulaitytė U; Paškevičiu Tė M; Cottiglia F; Gaspari M; Taverna D; Deplano S; Fois B; Maccioni E
ACS Med Chem Lett; 2019 Apr; 10(4):571-576. PubMed ID: 30996798
[TBL] [Abstract][Full Text] [Related]
35. Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity.
Mahmoud HK; Farghaly TA; Abdulwahab HG; Al-Qurashi NT; Shaaban MR
Eur J Med Chem; 2020 Dec; 208():112752. PubMed ID: 32947227
[TBL] [Abstract][Full Text] [Related]
36. Azide-Alkyne Cycloaddition En Route to 1
Singh A; Saha ST; Perumal S; Kaur M; Kumar V
ACS Omega; 2018 Jan; 3(1):1263-1268. PubMed ID: 30023800
[TBL] [Abstract][Full Text] [Related]
37. Enhancing Tumor Cell Response to Multidrug Resistance with pH-Sensitive Quercetin and Doxorubicin Conjugated Multifunctional Nanoparticles.
Daglioglu C
Colloids Surf B Biointerfaces; 2017 Aug; 156():175-185. PubMed ID: 28528134
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, anticancer activity and photostability of novel 3-ethyl-2-mercapto-thieno[2,3-d]pyrimidin-4(3H)-ones.
Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Tsenov JA
Eur J Med Chem; 2016 Nov; 123():69-79. PubMed ID: 27474924
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
[TBL] [Abstract][Full Text] [Related]
40. Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
Chen Z; Huang KY; Ling Y; Goto M; Duan HQ; Tong XH; Liu YL; Cheng YY; Morris-Natschke SL; Yang PC; Yang SL; Lee KH
J Nat Prod; 2019 Nov; 82(11):3065-3073. PubMed ID: 31718182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
